-
Synthetic Biology Market Set to Experience Significant Growth by 2031: Agilent Technologies Inc., GenScript, Amyris
29 Mar 2024 07:42 GMT
… Scientific
◘ Synbio Technologies
◘ Merck KGaA
◘ Agilent Technologies Inc.
◘ GenScript
◘ Amyris
◘ Eurofins Genomics … positions, along with their gross profits, sales volumes, sales revenue, manufacturing …
-
DNA/RNA Sample Extraction and Isolation Market Report- Expansive Coverage on the Profit Sources
28 Mar 2024 22:07 GMT
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global DNA/RNA Sample Extraction and Isolation Market- (By Product (Consumables (Kits (DNA Kits, RNA Kits), Reagents), Instruments), By Technology ( …
-
Agilent Technologies Q1 Profit Decreases, but beats estimates
27 Feb 2024 21:39 GMT
Agilent Technologies (A) announced earnings for first quarter that decreased from the same period last year but beat the Street estimates.
The company's earnings totaled $348 million, or $1.18 per share. This compares with $352 million, or $1.19 per …
-
Microfluidic Market Mapping the Growth Trajectory of size by 2031 | Agilent Technologies, PerkinElmer Inc, Qiagen NV
21 Feb 2024 07:30 GMT
… studied in the report include:Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific … market competition based on sales, profits, and market division of each …
-
Single-cell Omics Market Is Booming Worldwide 2024-2031 | Agilent Technologies Inc., QIAGEN N.V., Illumina Inc., Roche
06 Feb 2024 10:27 GMT
… Report:
◘ Bio-Rad Laboratories Inc.
◘ Agilent Technologies Inc.
◘ QIAGEN N.V.
◘ Thermo … mentioned in this report. The profitable segments/subsegments for the …
-
Genome Editing Market To Rapid Growth by 2032 | Agilent Technologies, Eurofins Scientific, GenScript
02 Feb 2024 22:38 GMT
… in the field, such as Agilent Technologies, CRISPR Therapeutics, Danaher, Eurofins … price, sales, and cost/profit.
Demand & Supply and …
Genome Editing Market Key Players: Agilent Technologies, CRISPR Therapeutics, Danaher, Eurofins …
-
Earnings: Agilent’s (A) Q1 2024 profit declines on lower revenues
28 Feb 2024 19:12 GMT
Healthcare company Agilent Technologies Inc. (NYSE: A) reported a decrease in adjusted earnings for the first quarter of 2024 when its revenues dropped 6% year-over-year.
Net income, on a reported basis, came in at $348 million or $1.18 per share in Q1, …
-
What Makes Agilent Technologies (A) a Good Investment Choice?
09 Jan 2024 10:48 GMT
… stated the following regarding Agilent Technologies, Inc. (NYSE:A): “Agilent Technologies, Inc. (NYSE: … software, which are more profitable and less volatile than capital … attractive growth rates, robust profitability and resiliency. Company executives …
-
Agilent Technologies Q4 Profit Increases, beats estimates
20 Nov 2023 21:59 GMT
Agilent Technologies (A) reported a profit for its fourth quarter that … ;s fourth quarter.
Excluding items, Agilent Technologies reported adjusted earnings of $404 … $1.85 billion last year.
Agilent Technologies earnings at a glance (GAAP …
-
Agilent Technologies 4Q Profit Rises Despite Revenue Decline
20 Nov 2023 21:24 GMT
By Denny Jacob Agilent Technologies logged a higher profit despite a decline in revenue …